Presumed bilateral diffuse uveal melanocytic proliferation - A case report and review of literature
© 2022 The Authors..
Purpose: To describe a case of presumed bilateral diffuse uveal melanocytic proliferation (BDUMP) associated with renal cell carcinoma (RCC) and provide an updated review of literature.
Observations: A 58-year-old man, with a history of radical nephrectomy for RCC 8 years ago, presented with gradual diminution of vision. Based on multimodal imaging and detailed systemic evaluation, a diagnosis of presumed BDUMP and metastatic RCC was made. He was started on sunitinib malate as palliative chemotherapy. However, he refused plasmapheresis for BDUMP. The patient rapidly developed bilateral exudative retinal detachment. Subsequently, he progressed to bilateral neovascular glaucoma secondary to closed funnel retinal detachment. Eventually, he was lost to follow up after 13 months.
Conclusions & Importance: BDUMP portends an underlying advanced systemic malignancy. Studies have not conclusively proven any definite treatment for BDUMP and survival is generally poor. Ocular side effects of palliative targeted chemotherapy for the primary malignancy, such as sunitinib, should be borne in mind.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:27 |
|---|---|
| Enthalten in: |
American journal of ophthalmology case reports - 27(2022) vom: 18. Sept., Seite 101582 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Parakh, Shweta [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Bilateral diffuse uveal melanocytic proliferation |
|---|
| Anmerkungen: |
Date Revised 16.07.2022 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.ajoc.2022.101582 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM341423181 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM341423181 | ||
| 003 | DE-627 | ||
| 005 | 20231226011740.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ajoc.2022.101582 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1138.xml |
| 035 | |a (DE-627)NLM341423181 | ||
| 035 | |a (NLM)35619994 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Parakh, Shweta |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Presumed bilateral diffuse uveal melanocytic proliferation - A case report and review of literature |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 16.07.2022 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2022 The Authors. | ||
| 520 | |a Purpose: To describe a case of presumed bilateral diffuse uveal melanocytic proliferation (BDUMP) associated with renal cell carcinoma (RCC) and provide an updated review of literature | ||
| 520 | |a Observations: A 58-year-old man, with a history of radical nephrectomy for RCC 8 years ago, presented with gradual diminution of vision. Based on multimodal imaging and detailed systemic evaluation, a diagnosis of presumed BDUMP and metastatic RCC was made. He was started on sunitinib malate as palliative chemotherapy. However, he refused plasmapheresis for BDUMP. The patient rapidly developed bilateral exudative retinal detachment. Subsequently, he progressed to bilateral neovascular glaucoma secondary to closed funnel retinal detachment. Eventually, he was lost to follow up after 13 months | ||
| 520 | |a Conclusions & Importance: BDUMP portends an underlying advanced systemic malignancy. Studies have not conclusively proven any definite treatment for BDUMP and survival is generally poor. Ocular side effects of palliative targeted chemotherapy for the primary malignancy, such as sunitinib, should be borne in mind | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Bilateral diffuse uveal melanocytic proliferation | |
| 650 | 4 | |a Neovascular glaucoma | |
| 650 | 4 | |a Plasmapheresis | |
| 650 | 4 | |a Renal cell carcinoma | |
| 650 | 4 | |a Sunitinib | |
| 700 | 1 | |a Maheshwari, Shrey |e verfasserin |4 aut | |
| 700 | 1 | |a Das, Shrutanjoy |e verfasserin |4 aut | |
| 700 | 1 | |a Kumar, Vinod |e verfasserin |4 aut | |
| 700 | 1 | |a Agrawal, Rupesh |e verfasserin |4 aut | |
| 700 | 1 | |a Gupta, Vishali |e verfasserin |4 aut | |
| 700 | 1 | |a Mruthyunjaya, Prithvi |e verfasserin |4 aut | |
| 700 | 1 | |a Luthra, Saurabh |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of ophthalmology case reports |d 2016 |g 27(2022) vom: 18. Sept., Seite 101582 |w (DE-627)NLM26009403X |x 2451-9936 |7 nnns |
| 773 | 1 | 8 | |g volume:27 |g year:2022 |g day:18 |g month:09 |g pages:101582 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ajoc.2022.101582 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 27 |j 2022 |b 18 |c 09 |h 101582 | ||